← All trials
NCT05373303
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 7, 2019
- Primary completion
- May 15, 2021
- Completion date
- Jan 28, 2022
- First posted
- May 13, 2022
- Last posted
- Jul 14, 2022
- Enrollment
- 82
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Daewoong Pharmaceutical Co. LTD.Lead sponsor
- Equilab InternationalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.